Medicare total spending hit $5.7 billion in 2022 for GLP-1 drugs such as Ozempic, Wegovy and Mounjaro, up from $57 million in 2018, according to a March 22 KFF analysis.
Payer
Humana is seeking to dismiss a class action lawsuit alleging the insurer used an AI algorithm to wrongfully deny Medicare Advantage beneficiaries care.
From new university partnerships to the launch of reproductive care teams, these are five key updates about Blue Cross Blue Shield companies recently reported by Becker's:
Private lawyers made at least $108 million in fees from payments Centene made to states to settle overcharging allegations, The New York Times reported March 21.
Ten providers recently posted job listings seeking leaders in payer contracting and relations.
Advertisement
A group of Republican lawmakers are asking CMS to reconsider its proposed 2025 rates for Medicare Advantage.
There are few statistically significant differences between the way primary care physicians treat patients in Medicare Advantage and fee-for-service Medicare, according to the Commonwealth Fund.
From chronic disease management to mental health investments, these are 10 partnerships announced by health insurers within the last year:
Georgia's alternative to expanding Medicaid under the ACA has cost $26.6 million through Dec. 31, with 90% of that money going toward administrative and consulting costs, KFF Health News reported March 20.
States and CMS can increase their oversight of denials by Medicaid managed care organizations, according to a report from the Government Accountability Office.